Infectious Disease


Are partnerships the key to making critical progress in Global Health?

When it comes to Global Health, there are a number of challenges that the global health community should be aware of and focused on. Many Read More

Republican health plan seen as a major setback for hepatitis C Medicaid patients

Amid a growing hepatitis C epidemic, federal austerity measures seen as a setback to infection control.  By Sony Salzman It’s been nearly 20 years since Read More

Meet the amazing cast behind a life-changing drug

It was well after midnight in San Francisco when Eugenio (“Geno”) de Hostos picked up the phone—but when his colleagues in China answered, he felt the familiar jolt of excitement. He’d felt the same thrill at dawn, talking to his colleagues in Switzerland. At five, in a call to Maryland with the US Food and […] ; ; ; ;Related StoriesWaking from sleeping sickness in the DRCThe surprising consequences of tuberculosisPATH is at SXSW ;


A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and…

Humans living in regions with high falciparum malaria transmission intensity harbour multi-strain infections comprised of several genetically distinct malaria haplotypes.

Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against <i>Naja…

by Chien-Chun Liu, Chen-Hsien You, Po-Jung Wang, Jau-Song Yu, Guo-Jen Huang, Chien-Hsin Liu, Wen-Chin Hsieh, Chih-Chuan Lin In Southeast Asia, envenoming resulting from cobra snakebites is an important public health issue in many regions, and antivenom therapy is the standard treatment for the snakebite. Because these cobras share a close evolutionary history, the amino acid sequences of major venom components in different snakes are very similar.

Genotyping of <i>Mycobacterium leprae</i> for better understanding of leprosy…

by Amanda N. B.

Most Zika-Affected Infants Experience Developmental Delays, Will Need Lifetime Care, CDC-Led…

New York Times: As Zika Babies Become Toddlers, Some Can’t See, Walk or Talk “As the first babies born with brain damage from the Zika epidemic become two-year-olds, the most severely affected are falling further behind in their development and will require a lifetime of care, according to a study published Thursday by the Centers…More

NTD Progress Report Shows Numbers Of People Affected By Diseases Down, 1B People Received…

Los Angeles Times: Guinea worm, river blindness and elephantiasis are among the world’s neglected tropical diseases. A battle is on to wipe them out “…[T]he combined efforts of governments, nonprofit organizations, academia, and the private sector have helped combat neglected tropical diseases, or NTDs, during the last five years, according to a report published Thursday…More

Thailand Works To Eliminate Malaria, Including Drug-Resistant Strains, By 2021

Reuters: Thailand battles drug-resistant malaria strains that imperil global campaign “Once a smuggling stop for Cambodia’s Khmer Rouge guerrillas, Thailand’s border town of Bo Rai finds itself on the frontline of a new battle against drug-resistant strains of malaria that could frustrate global attempts to stamp out the disease. Malaria killed about 445,000 people last…More

When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives,…

Oral artemisinin monotherapy (AMT), an important contributor to multi-drug resistant malaria, has been banned in Nigeria.

Virulence, pathology, and pathogenesis of Pteropine orthoreovirus (PRV) in BALB/c mice:…

by Kazutaka Egawa, Masayuki Shimojima, Satoshi Taniguchi, Noriyo Nagata, Hideki Tani, Tomoki Yoshikawa, Takeshi Kurosu, Shumpei Watanabe, Shuetsu Fukushi, Masayuki Saijo Background Cases of acute respiratory tract infection caused by Pteropine orthoreovirus (PRV) of the genus Orthoreovirus (family: Reoviridae) have been reported in Southeast Asia, where it was isolated from humans and bats. It is possible that PRV-associated respiratory infections might be prevalent in Southeast Asia.

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

by Alicia Ponte-Sucre, Francisco Gamarro, Jean-Claude Dujardin, Michael P. Barrett, Rogelio López-Vélez, Raquel García-Hernández, Andrew W. Pountain, Roy Mwenechanya, Barbara Papadopoulou Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem.

Emergence of melioidosis in the Indian Ocean region: Two new cases and a literature review

by Nicolas Allou, Olivier Martinet, Jérôme Allyn, Bruno Bouchet, Marie-Christine Jaffar-Bandjee, Thomas Galas, Nicolas Traversier, Olivier Belmonte Author summary: Melioidosis is a disease caused by bacteria called B. pseudomallei.

Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite…

by Madhu K. Sundaraneedi, Bemnet Tedla, Ramon M. Eichenberger, Luke Becker, Darren Pickering, Michael J.

At International Forum, Japan Pledges $2.9B To Help Countries Pursue UHC; U.N. SG Stresses Need…

Japan Times: Japan pledges $2.9 billion to support countries pursuing universal health coverage “Japan will contribute about $2.9 billion to programs combating infectious disease and treating young children in developing countries that are pursuing universal health coverage, Prime Minister Shinzo Abe said Thursday at an international forum on the topic in Tokyo. … Abe made…More

Global Estimates Of Annual Influenza Deaths Higher Than Previously Predicted, CDC Study Shows

PBS NewsHour: CDC says more people die of influenza worldwide than some experts have estimated “As many as 646,000 people may die from influenza each year worldwide, according to the latest estimates from the Centers for Disease Control and Prevention — a larger number than what other health experts have predicted in years past…” (Santhanam,…More

U.S. Investments Drive First Annual Increase In Funding For Neglected Diseases Research Since…

Devex: R&D for neglected diseases reliant on just two donors, G-FINDER report warns “…The G-FINDER report, released on Wednesday, tracks investments in drugs, vaccines, diagnostics, microbicides, and vector control products and also basic research across 33 neglected diseases — a group of diseases that lead to approximately 6.4 million deaths per year and disproportionately affect…More

Older Posts »